HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 8,449-8,460 of 27,277
Drug study icon
CompletedEUCTR 2007-003159-36

An eight-week, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of saredutant 100 mg once daily in combination with escitalopram 10 mg once daily in patient...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Finland
DepressionHistorical research record
Countries
France, Finland, Sweden
Sponsor
sanofi-aventis recherche & développement
Drug study icon
CompletedEUCTR 2005-003181-41

An eight-week, double-blind, placebo-controlled, multicenter study with paroxetine (20 mg q24) as positive control, evaluating the efficacy, safety and tolerability of a fixed dose of SR58611A (350...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
AnxietyHistorical research record
Countries
Austria, Estonia, Sweden
Sponsor
Sanofi-Synthelabo Recherche
Drug study icon
CompletedEUCTR 2008-001718-26

An eight-week, multicenter, randomized, double-blind, placebo-controlled dose-finding study, with escitalopram (10mg daily) as active control, to evaluate the efficacy, safety and tolerability of t...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Slovakia
DepressionHistorical research record
Countries
Slovakia
Sponsor
Sanofi-Aventis Recherche & Développement
Drug study icon
CompletedEUCTR 2006-003805-19

An eight-week, multinational, multicenter, randomized, double-blind, placebo-controlled study, with escitalopram as an active control, to evaluate the efficacy, safety and tolerability of a saredut...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
AnxietyHistorical research record
Countries
Belgium, Finland, Italy, + 1 other
Sponsor
sanofi-aventis recherche et développement
Other study type icon
CompletedNCT01455961

Real-World Treatment Patterns in Bipolarity Care in Sweden

About this title

An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder

Read the official source — NCT01455961
Official study title

An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder Treated With Quetiapine XR and/or Quetiapine IR

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityObservational study
Countries
Sponsor
AstraZeneca
Other study type icon
CompletedNCT01309373

Remission and Community Life in Schizophrenia Care

About this title

An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia

Read the official source — NCT01309373
Official study title

Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia (REINTEGRA Study)

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaObservational studyAges 18–65
Countries
Sponsor
Janssen-Cilag, S.A.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.